Lung cancer is the leading cause of cancer death. Dimerization and phosphorylation of the receptor tyrosine kinase are involved in the malignant progression of cancers and drug resistance. Focusing on the EGFR-ErbB3 dimerization, we build a mathematical model using ordinary differential equations (ODEs). By classifying the molecules into two groups, we sum molecular ODEs into two groups and solve them explicitly. From these solutions, all molecule concentrations and their equilibria can be derived theoretically. Based on the theoretical solutions, we determine the dimerization behavior and a key parameter. Our model can be applied to similar dimerization networks.
Introduction
Lung cancer is the leading cause of cancer death worldwide, and lung adenocarcinoma is the most common subtype of lung cancer. In East Asia, mutation of the epidermal growth factor receptor (EGFR) gene is the most frequent cause of lung adenocarcinoma. Gefitinib, one of the EGFR tyrosine kinase inhibitors (EGFR-TKI), is clinically used as a molecularly targeted drug for lung adenocarcinoma in individuals harboring EGF R mutations. The effect of gefitinib is dramatic; however, tumor resistance to the drug inevitably arises in a few years. The known mechanisms of gefitinib resistance are the T790M secondary mutation of the EGF R gene (∼ 50%) and amplification of the MET gene, which encodes a receptor tyrosine kinase (4 ∼ 20%). The T790M mutation is believed to sterically block the binding of gefitinib, while MET activates the downstream signaling of EGFR through ErbB3, which is another receptor of tyrosine kinase. The restoration of the phosphorylated EGFR-ErbB3 heterodimer is considered to be the cause of gefitinib resistance. Fig. 1 is an image of the gefitinib resistance mechanism with MET amplification.
As a first step to understand this resistance mechanism, we focus on the EGFR-ErbB3 dimerization process. Several mathematical models have been built for this kind of dimerization process [1] [2] [3] , which show the time courses of the molecules by simulation. However, these mathematical models cannot be solved explicitly because they are nonlinear.
Previously we built ordinary differential equation (ODE) models for the extended Matrix metallopro- teinase2 (MMP2) activation network and derived ODE solutions and equilibria theoretically by classifying molecules to certain groups and summing molecular ODEs to group ODEs [4] [5] [6] . For the EGFR-ErbB3 dimerization, we built ODEs of the EGFR-ErbB3 dimerization and solved these ODEs by classifying the molecules into a monomer group and a dimer group. In the case of EGFR-ErbB3 dimerization, the molecules are classified into monomer and dimer groups. The molecular concentrations and the equilibria are also derived explicitly by this method.
Mathematical model of dimerization
We focus on the dimerization process of EGFR and ErbB3, because EGFR-ErbB3, as a heterodimer, causes gefitinib resistance by MET according to the work by Engelmann et al. [7] . We built ODEs in order to understand the effect of the reaction rules on the behavior of the pathway network. By understanding the effects of chemical reaction rules and their order on the behav-ior of the network, the evolution of the network can be predicted from the formations of complexes in it. The dimerization of A 1 and A 2 is given by
The concentrations of molecules
. The evolution equations of the concentrations are derived from the law of mass action and from the law of mass conservation. Firstly, let us consider a network consisting of A 1 and A 2 monomers. A scheme of molecular reactions is shown in Fig. 2 . To obtain the law of mass action in the signaling network, we define 
By assuming that this network is closed, the total number of A 1 or A 2 is preserved. From the law of mass conservation the following equations can be derived for A 1 or A 2 : 
Grouping and the group ODE model
We separate molecules into two groups: monomers (ξ) and dimers (η). The group concentrations at time t are defined as follows:
According to (2) and (3), the law of mass conservation for the groups can be written as
The values of association and dissociation rate constants and initial molecular concentrations are required for the calculation. Firstly, we assume that association rates
By summing the molecular ODEs in (1), by using (2)- (4) two group ODEs can be obtained:
The equilibrium of the monomer group ξ concentration ξ * ± can be obtained from (5) as follows:
The group ξ concentration at time t is
where
From (4), the dimer group concentration η(t) and its equilibrium η * can be derived:
The group concentrations and their equilibria are obtained from the association and dissociation constants and from the initial monomer concentrations. Next, we rebuild the model based on real data using Refs. [8] [9] [10] . From these data, the values of l 1 /k 1 In this case, the two group ODEs can be written as follows:
Compared to (5), the group ODEs in (10) have extra terms, k r X 1 (t)X 2 (t) and k r X 2 (t) 2 in the right-hand side. The orders of k r ξ(t) 2 . Although k r X 1 (t)X 2 (t) is small it is definitely not negligible. To understand the effect of the terms on the pathway network, we simulate (10) and (5) with association and dissociation rates k r and l r . Fig. 3 shows the time evolution of the group concentrations obtained from the simulation by (10) and the theoretical solution of (5) given by (7) and (8) . If 3k r X 1 (t)X 2 (t) and 29k r X 2 (t) 2 in (10) are negligible, then (10) is equal to (5) . The difference between (5) and (10) simulation results is two decimal places, which is due to the term k r X 1 (t)X 2 (t). The results indicate that the group ODEs in (5) decide the network behavior mainly.
Molecule concentration and equilibrium
In the previous section, the monomer and dimer group concentrations were derived from the group ODEs in (5), which are the main equations for the network. We assume that the association rate k = k 1 ≈ k 2 ≈ k 3 . The substitution of group concentrations ξ(t) and η(t) into (1) gives
The molecular equations above correspond to the gen-
The solution of the generalized equation is given by
(12) Its equilibrium X * can be written as
The equilibrium solutions of the monomer concentrations are
Nevertheless, the equilibrium of the dimer concentrations can also be obtained as Fig. 4 shows the concentrations of all molecules from simulation and theory, while Fig. 5 shows an enlarged version of the figure from it. The equilibrium values of all molecules are shown in Table 1 . The theoretical results are in good agreement with the simulation results.
Conclusion
We build an ODE model of biochemical reactions in the EGFR-ErbB3 dimerization process, which is an important process in the gefitinib resistance mechanism. Classifying the molecules into monomer and dimer groups, the solutions and equilibria of the groups and molecular ODEs are derived theoretically, using only association and dissociation rate parameters and initial monomer concentrations. We find that the group concentration ODEs (5) govern the pathway network behavior mainly. Using (11) and (15), we theoretically predict the molecule concentrations and equilibria and the convergence time to their equilibria, without ODE simulation. Then, an obvious relationship between the molecules in the network can be obtained. The initial concentration X 1 (0) + X 2 (0) of the monomer group is a key parameter in this network. Our results can be applied to similar kinds of dimerization networks, with similar chemical reaction rules. If the dimerization network is heterogenous, it is possible to apply this model by using compartments, in which the molecules are homogenous.
